Newsroom

Jan. 20, 2023

Study uncovers "mystery" of CD73 protein breakdown in triple negative breast cancer

A new pre-clinical study by Winship researchers suggests promising new strategies to improve the efficacy of immunotherapy in patients with triple negative breast cancer.

Jan. 4, 2023

New AI-based biomarker can help predict immunotherapy response for patients with lung cancer

Winship researchers and colleagues from several health care systems and universities have discovered a new AI-derived biomarker that uses routine imaging scans to help predict which patients with lung cancer will respond to immunotherapy.

Dec. 20, 2022

Why do many young cancer survivors forgo human papillomavirus vaccination?

Winship study uncovers certain vaccine-related concerns that should be addressed by health care providers.

Dec. 19, 2022

Study finds Medicaid expansion improves cancer survival outcomes for young adults

A large first-of-its-kind study finds that expanded Medicaid coverage under the Affordable Care Act leads to better survival outcomes for young adults newly diagnosed with cancer.

Dec. 15, 2022

Winship names two assistant directors to bolster training and research mission

Winship has appointed Renee Read, PhD, as assistant director for basic research, and Carlos Moreno, PhD, as assistant director for education and training.

Dec. 29, 2022

USA Today: Rep. Jamie Raskin's lymphoma diagnosis is serious but curable. Here's what to know.

Dec. 27, 2022

U.S. News and World Report: Obamacare May Have Helped Extend Lives of Young Cancer Patients

Oct. 19, 2022

Allure Magazine: There’s a lot in the news about hair relaxers and uterine cancer: how worried should we be?

Oct. 6, 2022

Georgia Public Broadcasting: 'There is no reason for Black women to have such high maternal mortality rates,' says health leader

Sep. 16, 2022

CBS News: New abortion laws jeopardize cancer treatment for pregnant patients

Jan. 23, 2023

Winship Weekly: January 23, 2023

Study uncovers "mystery" of CD73 protein breakdown in triple negative breast cancer | Winship’s Rockin’ Enrollers | Oza joins Department of Rehabilitation Medicine | Events | Publications | Funding Opportunities

Jan. 17, 2023

Winship Weekly: January 17, 2023

Winship’s pharmacies personalize medications and improve cancer outcomes | New AI-based biomarker may help predict immunotherapy response for patients with non-small cell lung cancer | New data for ER+ breast cancer: oral SERDs, pregnancy for young patients and emerging targets | Five reasons to schedule your next Pap smear | Policies and guidance for social media users | Events | Publications | Funding Opportunities

Jan. 9, 2023

Winship Weekly: January 9, 2023

New AI-based biomarker can help predict immunotherapy response for patients with lung cancer | Affordable Care Act may have helped extend lives of young patients with cancer | Madabhushi receives grant to study use of radiomics and pathomics to predict response to immune checkpoint inhibitors | Mandawat appointed to American College of Cardiology leadership council | Waller discusses B-cell lymphoma following Rep. Jamie Raskin's diagnosis | Second-line treatment options for EGFR TKI-resistant non-small cell lung cancer | Effect of the HER2-low classification breast cancer | The role of spirituality in cancer care | Events | Publications | Funding Opportunities

July 1, 2022

Winship Magazine : Spring 2022

In this issue: Racial Disparities in Cancer | The Team Approach | Emory Proton Therapy Center Completes Treatment for 2022nd Patient | How Science Became Hope | Winship's Midtown Tower and more.

Dec. 2, 2020

Winship Magazine : Fall 2020

In this issue: Using a Patient's Immune System to Fight Cancer | Going Above and Beyond | Keep cancer Research Running | The Winship 5K Comes Through | COVID-19 and Cancer and more.

Dec. 2, 2019

Winship Magazine : Fall 2019

In this issue: Gaining Ground on Lung Cancer | Targeting Metastasis through Metabolism | "Can You Help Me Live?" | Connecting with the Community | Run to Win | Mapping a Calmer Passage through Cancer and more.